ATX 0.00% 15.0¢ amplia therapeutics limited

Ann: Response to ASX Price Query, page-2

ANNOUNCEMENT SPONSORED BY PLUS500
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM
CFD Service. Your Capital is at risk
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
  1. 25,807 Posts.
    lightbulb Created with Sketch. 1252
    Good 'ol asx wait until most of the trades already happened
    and way after the top price.
    Joke of a regulator.
    " 1. The Company is not aware of any information concerning it that would, if known by some in the
    market, explain the recent trading in its securities. On 8 October 2020 the Company announced
    the dosing of the first subjects in its Phase 1 clinical trial of AMP945, the Company’s
    experimental Focal Adhesion Kinase inhibitor, which is being developed for difficult to treat
    cancers and fibrotic diseases. There have been no material developments of any description
    since that date.
    2. Not Applicable.
    3. The Company is not able to offer any explanation for the recent trading in its securities. The
    Company notes that recent press coverage may have contributed to raising the profile of the
    Company in the marketplace.
    4. The Company believes that it is in compliance with the Listing Rules and, in particular, Listing
    Rule 3.1.
 
watchlist Created with Sketch. Add ATX (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.